Projekt

A phase II, randomized, placebo controlled, double blind, multicenter study of fixed dose versus CRP-response-guided dose of lenalidomide (Revlimid®) in solid tumour patients with inflammatory cancer cachexia syndrome on muscle mass, muscle strength, physical functioning, inflammation, eating-related symptoms and nutritional intake

Automatisch geschlossen · 2009 bis 2011